Board Meeting Details
The Board of Directors of Aarti Drugs Limited will hold a meeting on Friday, July 31, 2026. The primary agenda of the meeting is to consider, approve, and take on record the Audited Financial Results for the quarter ended June 30, 2026.
Trading Window Closure
In continuation of the company's earlier intimation dated June 26, 2026, the trading window for dealing in the company's securities will remain closed until the expiry of 48 hours after the declaration of the financial results.
Additional Information
The disclosure mentions that this information is also available on the company's website at www.aartidrugs.com.
Authentication
The document is digitally signed by Rushikesh Vivek Deole, who holds the position of Company Secretary & Compliance Officer with ICSI Membership Number F12932.